Rate My Professor Stuart Jones

Professor Stuart Jones holds the Chair in Pharmaceutical Medicine in the Pharmacy Department of the Faculty of Life Sciences & Medicine at King’s College London, where he also serves as Director of the Centre for Pharmaceutical Medicine Research and Programme Director for the online Global Medicines Development MSc. He began his career in the pharmaceutical industry at Pfizer in Sandwich, Kent, before completing a PhD in inhaled formulation design under Professors Marc Brown and Gary Martin at King’s College London. Following his doctorate, he became Head of Research and Development at MedPharm Ltd, a dermal small-to-medium enterprise, and returned to academia 17 years ago with a lectureship at King’s College London, progressing to his current professorial position. Jones acts as a consultant to the pharmaceutical industry and serves as an expert witness in patent litigation. His research centres on the design of innovative pharmaceutical formulations and devices, particularly dynamic drug delivery systems for efficient topical administration to the skin, lung, nose, hair, and nail. Key projects include non-invasive skin biomarker sampling, modulation of skin keratinocyte function with natural compounds, gas-generating topical formulations, skin stretching for needleless vaccine delivery, nanomaterial applications in oral and respiratory mucosa, hair follicle targeting with nanosystems, and 3D-printed topical patches. He leads the Medicines Development Research Group, contributes to the Antimicrobial Research Theme and Multiscale Biofilm Research Hub, and investigates dermatological and non-mucosal biofilms in conditions such as dermatitis, chronic wounds, and nail infections. Jones has secured over £4 million in funding from 18 research grants, including £2.7 million for the OnchyMed device targeting nail fungal infections, supervised more than 30 PhD students, published over 80 research articles, and holds 8 patents. Notable publications include 'A multistage double-blind placebo-controlled study to assess the safety and efficacy of transdermal vitamin D phosphate supplementation (TransVitD)' (Trials, 2025), 'Transient skin stretching stimulates immune surveillance mechanisms' (Cell Reports, 2025), and 'Needleless administration of advanced therapies into the skin using transient micropore arrays' (Advanced Drug Delivery Reviews, 2022). He received the APS Science Award in 2022 and delivered his inaugural lecture in 2023.